Cargando…
Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936149/ https://www.ncbi.nlm.nih.gov/pubmed/35026789 http://dx.doi.org/10.1097/AOG.0000000000004700 |
_version_ | 1784672163462119424 |
---|---|
author | Thilagar, Bright P. Ghosh, Aditya K. Nguyen, Jerome Theiler, Regan N. Wick, Myra J. Hurt, Ryan T. Razonable, Raymund R. Ganesh, Ravindra |
author_facet | Thilagar, Bright P. Ghosh, Aditya K. Nguyen, Jerome Theiler, Regan N. Wick, Myra J. Hurt, Ryan T. Razonable, Raymund R. Ganesh, Ravindra |
author_sort | Thilagar, Bright P. |
collection | PubMed |
description | Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19). |
format | Online Article Text |
id | pubmed-8936149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-89361492022-04-01 Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) Thilagar, Bright P. Ghosh, Aditya K. Nguyen, Jerome Theiler, Regan N. Wick, Myra J. Hurt, Ryan T. Razonable, Raymund R. Ganesh, Ravindra Obstet Gynecol Contents Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19). Lippincott Williams & Wilkins 2022-04 2022-01-13 /pmc/articles/PMC8936149/ /pubmed/35026789 http://dx.doi.org/10.1097/AOG.0000000000004700 Text en © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Contents Thilagar, Bright P. Ghosh, Aditya K. Nguyen, Jerome Theiler, Regan N. Wick, Myra J. Hurt, Ryan T. Razonable, Raymund R. Ganesh, Ravindra Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title | Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title_full | Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title_fullStr | Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title_full_unstemmed | Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title_short | Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) |
title_sort | anti-spike monoclonal antibody therapy in pregnant women with mild-to-moderate coronavirus disease 2019 (covid-19) |
topic | Contents |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936149/ https://www.ncbi.nlm.nih.gov/pubmed/35026789 http://dx.doi.org/10.1097/AOG.0000000000004700 |
work_keys_str_mv | AT thilagarbrightp antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT ghoshadityak antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT nguyenjerome antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT theilerregann antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT wickmyraj antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT hurtryant antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT razonableraymundr antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 AT ganeshravindra antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19 |